• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Massive Bitcoin Options Expiry Worth $9.5 Billion Coming Up

user avatar

by Giorgi Kostiuk

2 years ago


Deribit, the leading crypto derivatives platform, is approaching a significant Bitcoin options expiry totaling over $9.5 billion, marking a substantial portion of the platform's total open interest, which stands at $26.3 billion currently. This unprecedented event highlights the increasing popularity of complex financial instruments among investors.

The levels of open interest are crucial indicators of market health and liquidity. Deribit's record-breaking figures demonstrate the maturation of the crypto market and its appeal to more experienced traders. The January and February expirations of $3.74 billion and $3.72 billion, respectively, are dwarfed by this upcoming expiration activity.

The anticipated impact on the Bitcoin price is heightened as Deribit analysts suggest around $3.9 billion worth of options might expire "in the money," potentially triggering a surge in buying activity and a subsequent increase in BTC price.

Experts point to a "max pain price" set at $50,000, representing the strike price where the most options expire worthless. This forecast could prompt significant speculative maneuvers aimed at managing positions and exploiting potential market fluctuations.

The forthcoming expiration of Bitcoin options on Deribit with a value of $9.5 billion presents a critical moment for the crypto market. Traders and investors will closely monitor Bitcoin's price evolution in response to this substantial event, presenting both opportunities for gains and risks of losses. This expiry could set the stage for heightened volatility across the crypto market.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Converge Bio's AI Platform Aims to Transform Drug Development

chest

Converge Bio is leveraging its newly acquired $25 million funding to enhance its AI platform, which focuses on drastically reducing the time and costs associated with drug development.

user avatarKenji Takahashi

Converge Bio Secures $25 Million Series A Funding to Transform Drug Discovery

chest

Converge Bio, a startup based in Boston and Tel Aviv, has raised $25 million in Series A funding to enhance AI-driven drug discovery.

user avatarMaria Fernandez

Buterin Continues Charity Donations from Token Sales

chest

Vitalik Buterin continues his practice of selling unsolicited tokens and donating the proceeds to charity, emphasizing ethical considerations in cryptocurrency promotions.

user avatarRajesh Kumar

Vitalik Buterin Sells Unsolicited Tokens for 94 ETH

chest

Ethereum cofounder Vitalik Buterin has sold unsolicited tokens from his wallet, converting them into 94 ETH.

user avatarGustavo Mendoza

Grayscale Segments Crypto Market into Five Vertical Categories

chest

Grayscale has categorized its altcoin candidates into five verticals, reflecting a structured approach to the crypto market.

user avatarMiguel Rodriguez

Decline in FLOW Price Amid Controversial Asset Recovery

chest

The price of FLOW has seen a significant decline following the Flow project's controversial asset recovery actions.

user avatarLuis Flores

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.